RxDoctor Payments Data

Sonu Dhillon, MD

Hepatology · Chicago, ILNPI 1225017593

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Boston Scientific at 30.0% of the total. That places this record below the midpoint for hepatology clinicians in IL, where the typical reported total is $2,385.

$995in general payments, 2019–2025

Across 9 payments — averaging $110.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$299
  • Conmed Corporation$279
  • Beone Medicines USA, Inc.$147
  • AbbVie$125
  • Merit Medical Systems Inc$104
  • Cook Medical LLC$42

What the payments were for

  • Food & beverage$995100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$995 in reported general payments places this provider in the 40th percentile of 21 hepatology providers in Illinois.

See all hepatology providers in Illinois

Medicare billing

Part B allowed, 2024
$164,725
Medicare patients
562
Services billed
1,432

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
HarvoniLedipasvir/Sofosbuvir11$331,778
MavyretGlecaprevir/Pibrentasvir11$142,689
Entecavir22$11,909
Ursodiol22$2,288
Spironolactone131$2,266
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates31$2,231
Lactulose27$1,734
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl123$1,712
Azathioprine15$1,384
ConstuloseLactulose19$1,175
Omeprazole101$901
Dicyclomine Hcl16$808
Pantoprazole Sodium70$685
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine14$568
Furosemide96$536

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieMavyret$125$142,68911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 21 hepatology providers in Illinois.

Other hepatology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →